Asthmanefrin Racephinephrine Inhalation Solution recall: CGMP Deviations
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free…
Why was Asthmanefrin Racephinephrine Inhalation Solution recalled?
CGMP Deviations: products were stored outside the drug label specifications.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and identifiers are part of this recall.
- Product
- Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free…
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Quantity
- 1 box
- Distribution
- Nationwide in the USA.
- Recall date
- August 17, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)